OPTIFORM Trademark

Trademark Overview

On Friday, September 3, 2010, a trademark application was filed for OPTIFORM with the United States Patent and Trademark Office. The USPTO has given the OPTIFORM trademark a serial number of 85122972. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, January 13, 2023. This trademark is owned by CATALENT PHARMA SOLUTIONS, INC.. The OPTIFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research services; chemical compound and chemical compound library research and development services; pharmaceutical research and development, namely, screening drug targets; pharmaceutical research and development, namely, automated screening of pharmaceutical and chemical compounds
optiform

General Information

Serial Number85122972
Word MarkOPTIFORM
Filing DateFriday, September 3, 2010
Status800 - REGISTERED AND RENEWED
Status DateFriday, January 13, 2023
Registration Number4168553
Registration DateTuesday, July 3, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2011

Trademark Statements

Goods and ServicesScientific research services; chemical compound and chemical compound library research and development services; pharmaceutical research and development, namely, screening drug targets; pharmaceutical research and development, namely, automated screening of pharmaceutical and chemical compounds

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 8, 2010
Primary Code042
First Use Anywhere DateMonday, August 9, 2010
First Use In Commerce DateMonday, August 9, 2010

Trademark Owner History

Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameCATALENT PHARMA SOLUTIONS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events

Event DateEvent Description
Friday, January 13, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, January 13, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, January 13, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, January 13, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 28, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, July 3, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 22, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 22, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 22, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 22, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 9, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, July 3, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 3, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, May 26, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, May 17, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 24, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, March 30, 2012USE AMENDMENT FILED
Monday, April 23, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 30, 2012TEAS STATEMENT OF USE RECEIVED
Wednesday, September 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 12, 2011SOU EXTENSION 1 GRANTED
Monday, September 12, 2011SOU EXTENSION 1 FILED
Monday, September 12, 2011TEAS EXTENSION RECEIVED
Tuesday, April 12, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2011PUBLISHED FOR OPPOSITION
Thursday, January 13, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 13, 2011ASSIGNED TO LIE
Thursday, December 16, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 15, 2010ASSIGNED TO EXAMINER
Wednesday, September 8, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 7, 2010NEW APPLICATION ENTERED

Related Keywords

optiform research pharmaceutical chemical development compound screening services namely automated compounds